P1118 Intensification thérapeutique après la metformine chez les diabétiques type 2 en France : chez quels patients, quels éléments de choix, importance de l’âge des patients ? Étude ENVISAGE

S. Halimi, S. Quéré, S. Dejager
  • Diabetes & Metabolism, March 2013, Elsevier
  • DOI: 10.1016/s1262-3636(13)71864-0

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

http://dx.doi.org/10.1016/s1262-3636(13)71864-0

The following have contributed to this page: Mr Stéphane Quéré